Days after France attempted to ban a genetically-modified strain of maize created by the controversial agricultural company Monsanto, based in St. Louis, Mo., the European Food Safety Authority (EFSA) rejected France's grounds for banning the maize, even though France believes the corn is harmful to the environment.
Shares of Agilent Technologies (NYSE: A), the No. 1 U.S. instrument maker, surged on Thursday after the company announced it’s biggest acquisition, the $2.2 billion takeover of Denmark’s Dako.
Rather than deal with business, directors of Yahoo (Nasdaq: YHOO), the No. 3 search engine, have been busy all week in the “resume embellishment” scandal that forced one director to quit and put the CEO under a cloud.
The Global Fund, a leading financier in the struggle against AIDS, tuberculosis and malaria, expects to have an additional $1.
GlaxoSmithKline Plc (NYSE: GSK) will begin a $2.6 billion hostile takeover bid for Human Genome Sciences (NASDAQ: HGSI), the company announced Wednesday.